UK Research and Innovation on 6 November 2026 said the UK government is providing over £52 million via UKRI for five healthcare AI research hubs, with partners adding a further £37.5 million in cash and in-kind support, according to a UKRI news release. A £1 million UKRI Life Science Programme contribution sits inside the £52 million figure. The announcement describes funding and research aims, not completed clinical outcomes.
UKRI executive champion for health research Christopher Deane said: “These five new hubs will improve the lives and livelihoods of people and patients right across the UK.” The five hubs named by UKRI are BRAINIAC (University of Exeter), BRAIN-SAFE (Imperial College London), HeartTech (King’s College London), CRISP (University of Southampton) and NORI (University of Sunderland).
What UKRI listed for each hub
UKRI says BRAINIAC will support NHS brain-health clinics using AI that combines blood tests, brain scans and memory tests, with an aim to speed diagnosis by up to 50% and involve more than 1,700 patients. BRAIN-SAFE focuses on pitch-side and car-crash head-impact tools. HeartTech centres on an AI wellbeing coach for cardiovascular disease with wearables. CRISP works on cough and breathing apps, wearables and rapid tests. NORI applies AI to routine eye scans for early signs of diabetes and heart disease. UKRI also cites prior hubs as having delivered the world’s first AI-assisted brain tumour surgery — a historical claim in the release, not a result of this funding round.
What Exeter published separately on BRAINIAC
The University of Exeter said the BRAINIAC hub is worth £20 million (£10 million from EPSRC and £10 million from partners), runs for six years across 11 universities and ten NHS sites, expects first clinics in 2029, aims to make assessment and diagnosis 30 to 50 per cent faster, to identify more than 40 per cent of people assessed at early risk before symptoms, to train more than 200 clinicians and engineers, and to support 10 to 20 small companies. Exeter cites about 982,000 people with dementia in the UK. Professor David Llewellyn said: “Nearly a million people in the UK have dementia, and the hardest problem is detecting the earliest changes so we know who can benefit from treatment and prevention.”
UKRI’s “up to 50%” faster-diagnosis wording and Exeter’s “30 to 50 per cent” / early-risk percentages are aims on their respective pages. They are not reported trial outcomes.
How this sits with other healthcare AI coverage
TSN has covered UCL work on AI heart MRI and survival, Google’s hypertension AI, and Fred Hutch neural models in prostate cancer research. Those stories concern models or product claims with their own evidence bars. The UKRI package is a multi-hub public research investment with partner match, aimed at earlier detection tools across brain, heart, respiratory and eye pathways.
What five funded hubs change before any clinic opens
In the announcements, the near-term change is organised funding and partnerships, not a new diagnostic already in routine NHS use. BRAINIAC’s Exeter detail puts first clinics in 2029, which sets a multi-year clock under the six-year hub. Cross-checking UKRI’s national framing with Exeter’s £20 million BRAINIAC breakdown keeps the money lines from being double-counted: the £52 million is UKRI’s five-hub pot; the £20 million is Exeter’s description of one hub inside that programme plus partners.
Success will show later as published clinic protocols, regulatory clearances and measured diagnostic intervals — not as the aspiration percentages in today’s releases. For UK patients and trusts, the practical near term is which NHS sites join which hub consortia and how data-sharing agreements are written as the hubs stand up. Keeping UKRI’s “up to 50%” phrasing and Exeter’s “30 to 50 per cent” aims in separate sentences avoids blending two press offices into one invented statistic.
Sources
- New technology to spot illness years earlier gets UKRI backing (UKRI, 6 November 2026)
- Exeter-led £20 million hub will create ten brain health clinics to help NHS reduce dementia risk (University of Exeter, 6 November 2026)
Related stories
- AI Heart MRI Readings Predict Survival Slightly Better Than Experts
- Google Smartwatch AI Flags Hypertension in Nature Study
- AI Tool Picks Out Aggressive Prostate Cancer in a 63-Biopsy Test
Follow @tsnmediahub on X for breaking AI news as it happens.
Follow on X
